In the current study we assessed the effect of multiple doses of oral anthocyanosides on full field absolute scotopic retinal threshold (SRT), full-field dark adaptation rate (DAR) and mesopic contrast sensitivity (MCS) in human subjects. SRT, DAR and MCS were chosen for a number of reasons described in detail in our previous report, the most important one being our recent finding that SRT, DAR and MCS are directly related to the ability to identify field targets at night.l D To the best of our knowledge, there is no published double-masked, placebo controlled, cross-over study on the effects of multiple oral administrations of different doses of anthocyanosides on night vision tests.
glycosides. The richest source is the blueberry plant (Vaccinium myrtillus). Compounds extracted from blueberries containing predominantly anthocyanosides were reported to improve night vision functions in human subjects after a multiple oral administration. [1] [2] [3] The exact biochemical influence of anthocyanosides on the neurosensory retina is not known. 4 -8 It has been speculated that anthocyanosides accelerate the resynthesis of rhodopsin 4 and modulate retinal enzymatic activity. s In a previous study we were unable to D. ZADOK, Y. LEVY, Y. GLOVINSKY detect a significant effect of anthocyanosides in a single oral dose on night vision of normal individuals. 9 In the current study we assessed the effect of multiple doses of oral anthocyanosides on full field absolute scotopic retinal threshold (SRT), full-field dark adaptation rate (DAR) and mesopic contrast sensitivity (MCS) in human subjects. SRT, DAR and MCS were chosen for a number of reasons described in detail in our previous report, the most important one being our recent finding that SRT, DAR and MCS are directly related to the ability to identify field targets at night.l D To the best of our knowledge, there is no published double-masked, placebo controlled, cross-over study on the effects of multiple oral administrations of different doses of anthocyanosides on night vision tests.
Subjects and methods
Subjects were 18 healthy male volunteers, 21-30 years of age (mean 26 ::'::: 2.1 years), who had a best corrected mesopic (1 foot-lambert) visual acuity of 20/25 or better (mean 20/22.5 ::'::: 2.0). Twelve subjects were emmetropic, and 6 had myopia from -5.00 D to -1.00 D, the greatest cylinder being 1.25 D in one case.
After obtaining their informed consent (approved by the Tel Aviv University Helsinki Committee), subjects were randomly assigned to one of three groups. Each group was given a different regimen of multiple oral administrations of 12 and 24 mg of anthocyanosides and a placebo, given twice daily for 4 days, as detailed in Table 1 . A 2 week washout period intervened between each 4 day treatment period.
The double-masked, placebo-controlled, cross-over study was carried out in the winter (January-February 1996). MCS, DAR and SRT were tested in that order, 1 day before and daily during the 4 day treatment period (3-5 h following the morning drug application). Tablets of Strix (Halsoprodukter, Forserum, Sweden) containing 12 mg anthocyanosides (blueberry extract) and 2 mg beta-carotene, and placebo tablets (CTS, Israel), were used. 
Results
There were no significant differences in the mean SRT (p = 0.12, Table 2 ) or DAR (p= 0.86, Table 3 ) values between the anthocyanoside-treated groups and the control group during the 4 day drug administration period (within-subject repeated measures ANOV A).
Nor were there significant differences in the mean values of MCS (average of 1.5, 3, 6, and 12 cpd) (p = 0.73, Table  4 ) between the anthocyanoside-treated groups and the control group during the 4 day drug administration (within-subject repeated measures ANOVA). Similar results (data not shown) were obtained for each of the 4 cpd rates of MCS: 1.5, 3, 6 and 12 cpd. The study had a power of 0.95 to detect a 0.1 log unit improvement in SRT and 0.5 log unit improvement in MCS.1 4
Discussion
Several scientific publications in the 1960s and early 1970s reported improvement of night vision functions in normal individuals after a multiple oral administration of anthocyanosides.1,15,16 Indeed, the authors of this paper found over 50 sites on the Internet which claim improvement of night vision following oral consumption of blueberries or blueberry-extract.
The ability to improve night vision functions of normal persons with anthocyanosides is attractive in view of the many complaints of difficulty driving or walking at night in subjects with no ocular disease. In the present study we found no effect of multiple-dose anthocyanosides on any of the three night vision tests previously found by us to be good predictors of actual night performance. lO Our findings contrast with those of studies carried out 20-30 years ago,l,15,16 probably because of differences in study design and populations. Our double-masked, placebo-controlled, crosscover study enabled more accurate evaluation of the parameters being tested. Moreover, anthocyanosides might have had no effect on the young subjects in our study who had excellent night vision, while they may imprc;>ve the scores in individuals with low or moderate night vision ability. The discrepancy in results could also be due to differences in extracts of blueberries from different parts of the world, which might contain unequal amounts of active ingredients other than anthocyanosides. Nevertheless, our inability to demonstrate a beneficial effect of anthocyanosides on night vision even with a multiple dose suggest that such claims as 'blueberry extracts improve your night vision' should be viewed with caution. However, our study measured the effect of 4 days of treatment, and perhaps a longer duration (2 weeks) of anthocyanoside treatment should be checked.
